Yet, testing capacity remains the foremost determinant of a country’s success in containing the virus. Lack of testing can paralyse any plan to curb the outbreak, as tracing and isolating COVID-19 suspects can only be done as much as the tests tell us.
We can see this in the high positivity rates of countries with lower testing capacity relative to their population size. While WHO has capped a maximum positivity rate at 5%, countries like Indonesia, Ukraine, Mexico, as well as several South American and African countries could hardly go below 15%. This is essentially the problem of low testing capacity.
University of Reading: ART STUDENTS HIGHLIGHT ENVIRONMENTAL THREATS IN VIRTUAL EXHIBITION indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.
IN FOCUS: The fight against Jakarta’s devastating yearly floods Toggle share menu
Advertisement
IN FOCUS: The fight against Jakarta’s devastating yearly floods The Indonesian government is exploring multiple options to contain the worsening floods, but there are obstacles including climate change and illegal settlements.
Aerial picture of an area affected by floods, next to Ciliwung river in Jakarta, Indonesia January 2 2020, in this photo taken by Antara Foto. (File photo: Antara Foto/Nova Wahyudi/via REUTERS)
08 Feb 2021 05:00PM) Share this content
Bookmark
JAKARTA: As thunderous clouds roll in from the sea, Jakarta residents brace themselves for a familiar scenario.
Published on: Saturday, January 30, 2021
By: Antara News
Researchers in the state-run vaccine maker PT Bio Farma in Bandung, West Java.
JAKARTA: The second dose of China’s Sinovac vaccine has been administered across the country since January 27, mostly to healthcare workers at the frontlines of the fight against the Covid-19 pandemic.
Since the first coronavirus infections emerged on March 2, 2020, Indonesia has chalked up 1,037,99 confirmed Covid-19 cases and 29,331 deaths, according to data recorded as of January 28, 2021.
Under its vaccine programme, the government is targeting to inoculate 181.5 million people, free of charge, out of the total population of 271 million.
ADVERTISEMENT
Indonesia received 15 million doses of the bulk vaccine from Sinovac to be manufactured into individual doses by Bio Farma. The Food and Drug Supervisory Agency (BPOM) has issued a certificate for Good Manufacturing Practices (CPOB), or a permit, to Bio Farma to commence the production of C
Indonesia strives for vaccine self-reliance in COVID fight 28th January 2021
Researchers in the state-run vaccine maker PT Bio Farma in Bandung, West Java. ANTARA/Dhemas Reviyanto/foc. The second dose of China’s Sinovac vaccine has been administered across the country since January 27, 2021, mostly to healthcare workers at the frontlines of the fight against the COVID-19 pandemic.
Since the first coronavirus infections emerged on March 2, 2020, Indonesia has chalked up 1,037,99 confirmed COVID-19 cases and 29,331 deaths, according to data recorded as of January 28, 2021.
Under its vaccine program, the government is targeting to inoculate 181.5 million people, free of charge, out of the total population of 271 million.